Continental Advisors LLC Johnson & Johnson Transaction History

Continental Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $607,099 - $689,446	-3,839 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $268,736 - $298,638	-1,664 Reduced 30.24%	3,839 $620,000
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $603,078 - $670,572	-4,797 Reduced 46.57%	5,503 $769,000
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $663,336 - $798,336	5,400 Added 110.2%	10,300 $1.33 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $314,928 - $344,688	-2,400 Reduced 32.88%	4,900 $685,000
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $945,131 - $988,274	7,300	7,300 $949,000

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Continental Advisors LLC with notifications on news.